INVENTIVA SA (IVA.PA) Fundamental Analysis & Valuation

EPA:IVA • FR0013233012

Current stock price

4.37 EUR
-0.13 (-2.89%)
Last:

This IVA.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IVA.PA Profitability Analysis

1.1 Basic Checks

  • IVA had negative earnings in the past year.
  • IVA had a negative operating cash flow in the past year.
  • In the past 5 years IVA always reported negative net income.
  • IVA had a negative operating cash flow in each of the past 5 years.
IVA.PA Yearly Net Income VS EBIT VS OCF VS FCFIVA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100M -200M -300M

1.2 Ratios

  • IVA has a Return On Assets of -141.93%. This is amonst the worse of the industry: IVA underperforms 86.42% of its industry peers.
Industry RankSector Rank
ROA -141.93%
ROE N/A
ROIC N/A
ROA(3y)-151.84%
ROA(5y)-108.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IVA.PA Yearly ROA, ROE, ROICIVA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1K 2K 3K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IVA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IVA.PA Yearly Profit, Operating, Gross MarginsIVA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2K -4K -6K -8K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. IVA.PA Health Analysis

2.1 Basic Checks

  • IVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IVA has more shares outstanding
  • IVA has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for IVA has been reduced compared to a year ago.
IVA.PA Yearly Shares OutstandingIVA.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
IVA.PA Yearly Total Debt VS Total AssetsIVA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • Based on the Altman-Z score of -2.01, we must say that IVA is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of IVA (-2.01) is worse than 70.37% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.01
ROIC/WACCN/A
WACC7.78%
IVA.PA Yearly LT Debt VS Equity VS FCFIVA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M -100M

2.3 Liquidity

  • A Current Ratio of 3.16 indicates that IVA has no problem at all paying its short term obligations.
  • IVA has a better Current ratio (3.16) than 61.73% of its industry peers.
  • IVA has a Quick Ratio of 3.16. This indicates that IVA is financially healthy and has no problem in meeting its short term obligations.
  • IVA's Quick ratio of 3.16 is fine compared to the rest of the industry. IVA outperforms 64.20% of its industry peers.
Industry RankSector Rank
Current Ratio 3.16
Quick Ratio 3.16
IVA.PA Yearly Current Assets VS Current LiabilitesIVA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. IVA.PA Growth Analysis

3.1 Past

  • IVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.23%, which is quite impressive.
  • Looking at the last year, IVA shows a very negative growth in Revenue. The Revenue has decreased by -51.26% in the last year.
  • Measured over the past years, IVA shows a very strong growth in Revenue. The Revenue has been growing by 64.51% on average per year.
EPS 1Y (TTM)22.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.34%
Revenue 1Y (TTM)-51.26%
Revenue growth 3Y-28.33%
Revenue growth 5Y64.51%
Sales Q2Q%-100%

3.2 Future

  • Based on estimates for the next years, IVA will show a very strong growth in Earnings Per Share. The EPS will grow by 23.17% on average per year.
  • IVA is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 137.68% yearly.
EPS Next Y40.18%
EPS Next 2Y12.1%
EPS Next 3Y17.02%
EPS Next 5Y23.17%
Revenue Next Year-73.92%
Revenue Next 2Y48.99%
Revenue Next 3Y151.49%
Revenue Next 5Y137.68%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IVA.PA Yearly Revenue VS EstimatesIVA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 500M 1B
IVA.PA Yearly EPS VS EstimatesIVA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1 2 -2 3

More info and screens

Find the best growth stocksShow best growing peers

0

4. IVA.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • IVA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year IVA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IVA.PA Price Earnings VS Forward Price EarningsIVA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IVA.PA Per share dataIVA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1 -1.5 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as IVA's earnings are expected to grow with 17.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.1%
EPS Next 3Y17.02%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. IVA.PA Dividend Analysis

5.1 Amount

  • No dividends for IVA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

IVA.PA Fundamentals: All Metrics, Ratios and Statistics

INVENTIVA SA

EPA:IVA (4/24/2026, 7:00:00 PM)

4.37

-0.13 (-2.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-30
Earnings (Next)05-25
Inst Owners38.4%
Inst Owner ChangeN/A
Ins Owners4.48%
Ins Owner ChangeN/A
Market Cap907.69M
Revenue(TTM)4.48M
Net Income(TTM)-354.14M
Analysts88.75
Price Target12.79 (192.68%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.38%
PT rev (3m)-5.72%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.93%
EPS NY rev (3m)6.72%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-12.51%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 202.47
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.29
EYN/A
EPS(NY)-0.92
Fwd EYN/A
FCF(TTM)-0.51
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS0.02
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -141.93%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-151.84%
ROA(5y)-108.6%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 7.66%
Cap/Sales 5.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.16
Quick Ratio 3.16
Altman-Z -2.01
F-Score4
WACC7.78%
ROIC/WACCN/A
Cap/Depr(3y)11.62%
Cap/Depr(5y)N/A
Cap/Sales(3y)4.07%
Cap/Sales(5y)5.91%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.34%
EPS Next Y40.18%
EPS Next 2Y12.1%
EPS Next 3Y17.02%
EPS Next 5Y23.17%
Revenue 1Y (TTM)-51.26%
Revenue growth 3Y-28.33%
Revenue growth 5Y64.51%
Sales Q2Q%-100%
Revenue Next Year-73.92%
Revenue Next 2Y48.99%
Revenue Next 3Y151.49%
Revenue Next 5Y137.68%
EBIT growth 1Y-31.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-3.54%
EBIT Next 3Y16.18%
EBIT Next 5Y36.41%
FCF growth 1Y-21.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-22.06%
OCF growth 3YN/A
OCF growth 5YN/A

INVENTIVA SA / IVA.PA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of INVENTIVA SA (IVA.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to IVA.PA.


Can you provide the valuation status for INVENTIVA SA?

ChartMill assigns a valuation rating of 0 / 10 to INVENTIVA SA (IVA.PA). This can be considered as Overvalued.


What is the profitability of IVA stock?

INVENTIVA SA (IVA.PA) has a profitability rating of 0 / 10.


Can you provide the financial health for IVA stock?

The financial health rating of INVENTIVA SA (IVA.PA) is 3 / 10.


What is the expected EPS growth for INVENTIVA SA (IVA.PA) stock?

The Earnings per Share (EPS) of INVENTIVA SA (IVA.PA) is expected to grow by 40.18% in the next year.